Related Experiment Video
Updated: May 17, 2026
Retzius-Sparing Robot-Assisted Radical Prostatectomy
Published on: May 19, 2022
Perineal radical prostatectomy in the minimally invasive era
Jorge Rioja1, Anibal Rincon Mayans, Raul O Parra
1Department of Urology, Hospital Universitario Miguel Servet, Zaragoza, Spain. jriojazu@gmail.com
Abstract:
Radical prostatectomy is currently the standard of care for localized prostate cancer. In the last decade, the minimally invasive surgery, especially the robotic surgery has been growing and open techniques are less frequent performed. A non-systematic review of the literature is performed, highlighting the current situation of the perineal radical prostatectomy in the minimally invasive era, its indications, and functional and oncological outcomes. Radical perineal prostatectomy, when compared with other surgical approaches, still experience favorable outcomes. Urologist might be abandoning an underused surgical approach.
Insights
Radical perineal prostatectomy offers favorable outcomes for localized prostate cancer, even in the minimally invasive surgery era. Urologists may be overlooking this effective, underused surgical approach.
Area of Science:
- Urology
- Surgical Oncology
Background:
- Radical prostatectomy is the standard treatment for localized prostate cancer.
- Minimally invasive and robotic surgeries have become increasingly prevalent, reducing the use of open techniques.
Purpose of the Study:
- To review the current status of perineal radical prostatectomy in the context of minimally invasive surgery.
- To highlight its indications, and functional and oncological outcomes.
Main Methods:
- A non-systematic literature review was conducted.
Main Results:
- Perineal radical prostatectomy demonstrates favorable outcomes when compared to other surgical approaches.
- This surgical technique remains a viable option with positive results.
Conclusions:
- Urologists might be neglecting a valuable and underutilized surgical option.
- Perineal radical prostatectomy should be reconsidered as a standard approach for localized prostate cancer.
